Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, March 19, 2015, 56 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $59.05 to $2,925,000.00.

Highlighted Stocks Traded by Insiders:

Willis Lease Finance (WLFC) - FREE Research Report

Coon W William Jr, who is Shareholder at Willis Lease Finance, sold 1,428 shares at $19.52 on March 19, 2015. Following this transaction, the Shareholder owned 4,402 shares meaning that the stake was reduced by 24.49% with the 1,428-share transaction.

The shares most recently traded at $19.19, down $0.33, or 1.73% since the insider transaction. Historical insider transactions for Willis Lease Finance go as follows:

  • 4-Week # shares bought: 891
  • 4-Week # shares sold: 5,250
  • 12-Week # shares bought: 891
  • 12-Week # shares sold: 5,250
  • 24-Week # shares bought: 891
  • 24-Week # shares sold: 31,638

The average volume for Willis Lease Finance has been 9,900 shares per day over the past 30 days. Willis Lease Finance has a market cap of $160.1 million and is part of the services sector and diversified services industry. Shares are down 12.42% year-to-date as of the close of trading on Thursday.

Willis Lease Finance Corporation is engaged in leasing commercial aircraft engines and equipment worldwide. The company leases commercial aircraft engines and other aircraft-related equipment to air carriers, manufacturers, and overhaul/repair facilities. The company has a P/E ratio of 21.6. Currently, there are no analysts who rate Willis Lease Finance a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WLFC - FREE

TheStreet Quant Ratings rates Willis Lease Finance as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels and compelling growth in net income. However, as a counter to these strengths, we also find weaknesses including generally higher debt management risk and weak operating cash flow. Get the full Willis Lease Finance Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

KCG Holdings (KCG) - FREE Research Report

Daniel V. Tierney 2011 Trust, who is 10% Owner at KCG Holdings, sold 71,344 shares at $12.81 on March 19, 2015. Following this transaction, the 10% Owner owned 8.9 million shares meaning that the stake was reduced by 0.8% with the 71,344-share transaction.

The shares most recently traded at $12.50, down $0.31, or 2.48% since the insider transaction.

The average volume for KCG Holdings has been 305,800 shares per day over the past 30 days. KCG Holdings has a market cap of $1.5 billion and is part of the financial sector and financial services industry. Shares are up 6.7% year-to-date as of the close of trading on Thursday.

KCG Holdings, Inc., an independent securities firm, provides various services designed to address trading needs across asset classes, product types, and time zones. The company operates through three segments: Market Making, Global Execution Services, and Corporate and Other. The company has a P/E ratio of 23.3. Currently, there are 2 analysts who rate KCG Holdings a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on KCG - FREE

TheStreet Quant Ratings rates KCG Holdings as a sell. The company's weaknesses can be seen in multiple areas, such as its poor profit margins and relatively poor performance when compared with the S&P 500 during the past year. Get the full KCG Holdings Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Albany Molecular Research (AMRI) - FREE Research Report

Hagen Steven R, who is SVP Manufacturing & Pharmaceut at Albany Molecular Research, sold 3,500 shares at $18.53 on March 19, 2015. Following this transaction, the SVP Manufacturing & Pharmaceut owned 27,700 shares meaning that the stake was reduced by 11.22% with the 3,500-share transaction.

The shares most recently traded at $18.96, up $0.43, or 2.27% since the insider transaction. Historical insider transactions for Albany Molecular Research go as follows:

  • 4-Week # shares bought: 30,000
  • 4-Week # shares sold: 41,162
  • 12-Week # shares bought: 30,000
  • 12-Week # shares sold: 122,785
  • 24-Week # shares bought: 60,000
  • 24-Week # shares sold: 242,785

The average volume for Albany Molecular Research has been 512,800 shares per day over the past 30 days. Albany Molecular Research has a market cap of $610.4 million and is part of the health care sector and drugs industry. Shares are up 16.34% year-to-date as of the close of trading on Thursday.

Albany Molecular Research, Inc., a contract research and manufacturing company, provides integrated drug discovery, development, and manufacturing services primarily in the United States, Europe, and Asia. Currently, there are 2 analysts who rate Albany Molecular Research a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on AMRI - FREE

TheStreet Quant Ratings rates Albany Molecular Research as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and poor profit margins. Get the full Albany Molecular Research Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

null